Orchid Pharma Limited
Orchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs.
What Orchid files
- Others47
- Investor Meet27
- Important22
- Board Meeting13
- Updates6
- PPTs5
Orchid Pharma Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report for FY 2025-26'.
Orchid Pharma Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 29, 2026
Orchid Pharma Limited has informed the Exchange about appointment of cost auditor and change in designation of a Director.
Orchid Pharma's board has announced a meeting that approved the appointment of M/s. J Karthikeyan & Associates as Cost Auditors for FY2026-27 and Mr. Arjun Dhanuka as Whole-Time Director. The 33rd Annual General Meeting is scheduled for September 29, 2026.
**Financial Performance:** Orchid Pharma's Q1 FY27 revenue grew 15% YoY to INR304 Cr, with EBITDA more than doubling to INR25 Cr, showing recovery from a tough FY26. Gross margin improved to 33% from 30%. **Operational & Strategic Updates:** The 7-ACA backward integration project is on track for its first commercial...